Precision BioSciences Inc

Healthcare · Biotechnology

6.30$ -0.3% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Precision BioSciences Inc (DTIL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 126 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet DTIL
Line item	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	73	–	–	–	139	167	272	260	235	214	184	169	150	262	230	227	211	181	297	272	238	205	182	164	160	185	166	153	136	124	109	94	154	144	126
Current Assets	64	–	–	–	116	137	237	220	194	167	137	123	106	219	188	183	162	134	248	225	199	169	148	146	136	161	144	111	95	82	70	52	119	109	92
Cash	63	–	–	–	103	116	226	206	181	154	127	104	90	193	174	160	144	116	184	212	190	158	138	122	117	138	124	99	86	77	62	45	111	99	86
Cash & Short-Term Investments	–	–	–	–	103	116	226	206	181	154	127	104	90	193	174	160	144	116	184	212	190	158	138	122	117	138	124	101	86	77	62	45	116	101	88
Receivables	0.0	–	–	–	0.5	6.2	0.3	0.3	1.0	3.9	0.1	10	10	19	0.5	0.5	0.5	0.5	51	0.7	0.7	0.7	0.7	15	13	13	14	1.5	1.7	0.0	5.7	0.0	0.0	4.0	0.0
Inventory	–	–	–	–	–	8.3	8.3	11	9.5	7.9	10	8.2	5.8	6.4	8.5	21	17	17	13	12	7.6	8.4	8.9	–	–	–	–	–	–	–	–	–	–	–	–
Property, Plant & Equipment	8.1	–	–	–	21	28	33	39	40	45	44	43	42	34	39	37	25	24	27	22	20	19	23	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	0.6	0.6	–	–	–	–
Intangible Assets	0.1	–	–	–	1.5	1.5	1.5	1.4	1.4	1.4	1.4	1.4	1.4	1.4	1.3	2.1	2.0	2.0	2.0	2.0	0.7	1.5	1.6	1.0	0.4	0.4	0.4	0.4	0.6	0.6	0.6	1.0	1.2	1.1	1.1
Total Liabilities	99	–	–	–	99	156	98	105	97	99	99	105	106	203	130	126	120	112	194	187	178	164	148	135	141	148	91	88	80	75	75	77	62	68	81
Current Liabilities	9.2	–	–	–	14	71	16	24	27	24	34	42	43	64	36	36	36	29	54	61	60	47	56	51	50	33	33	12	15	12	14	15	8.9	7.8	7.1
Short-Term Debt	–	–	–	–	3.3	52	5.4	–	6.8	1.7	1.8	1.9	1.9	2.0	4.5	4.6	1.8	1.9	1.9	2.0	1.7	4.2	25	24	24	24	24	1.3	1.3	1.4	1.4	1.5	1.5	1.6	1.6
Accounts Payable	1.8	–	–	–	2.2	5.1	2.9	4.5	2.0	1.8	1.6	1.0	0.8	0.4	0.5	0.5	1.1	0.7	0.8	1.1	0.7	0.7	0.8	0.5	3.0	1.1	1.1	1.0	1.3	0.9	1.1	1.3	0.3	0.9	0.8
Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	2.5	2.5	22	22	22	22	–	–	–	–	–	22	22	22	22	22	22	–	22
Shareholders' Equity	-26	-26	–	–	40	11	174	156	138	115	86	64	44	59	101	101	91	70	103	84	60	40	34	29	19	37	75	65	56	49	34	17	92	76	45
Retained Earnings	-39	–	–	–	-85	-116	-135	-156	-177	-204	-237	-263	-286	-305	-283	-294	-317	-345	-376	-400	-428	-453	-465	-473	-490	-481	-448	-465	-482	-503	-527	-548	-528	-547	-579
Shares Outstanding	–	1.1	1.1	1.1	1.1	1.7	1.7	1.7	1.7	1.7	1.7	1.7	1.8	1.9	2.0	2.0	2.0	2.0	2.3	3.7	3.7	3.7	3.8	3.8	4.5	5.1	7.0	7.3	6.9	9.0	11	12	19	25	26

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings